Chiesi is partnering with eHealth Hub and its Solution Match service to source one or more solution partner(s) to revolutionize neo-natal care. 

 

For decades, Chiesi has been committed to neonatology, working alongside the medical community to improve the level of care for preterm babies. Thanks to this important relationship, Chiesi has become a global partner for neonatologists, bringing its life-saving drugs to more than 80 countries worldwide, and working towards the sharing of best clinical practices.

Chiesi has the ambition to innovate the entire journey of premature babies and their parents/families. In that context, Chiesi is looking for SME partners and solutions to improve/innovate premature environment for better life and development. Any solution addressing or contributing to address daily situations faced by/with premature babies will be considered and are welcome to apply.

Chiesi has identify 5 challenges they would like to work on with innovative European SMEs:

  • Challenge 1: Propose a solution for stable containment, safe transportation and best postural care
    of premature babies.
  • Challenge 2: Propose a set of devices that would support simple, safe and fast interactions with the premature babies and promote a healthy environment for their neurological development.
  • Challenge 3: Propose a solution that maintains two-way communications and allows
    parents and neonates to stay connected.
  • Challenge 4: Propose a solution that will help reduce and/or prevent skin damages.
  • Challenge 5: Propose a solution to limit and/or prevent environmental stress and manage these reduces levels of stress.

The solution to be implemented in a medical environment could be:

  • An existing solution that matches the need
  • An existing solution that can be adapted and co-developed with Chiesi to match the need
  • A new innovative concept that can be co-developed from scratch with Chiesi to match the need

If you are working on a different solution improving neo-natal care, Chiesi is still ready to support your initiative and would like to hear from you!

Chiesi is open to discussing various types of business collaborations, including the procurement of devices and services and investments in or acquisition of selected companies.

 

Operational calendar:

 

  • Call for application deadline: April 18
  • Application review: April 23-27
  • Announcement of finalists: April 30
  • Solution Match Live event: May 28 in Sitges as part of Health 2.0 Europe 2018

Contact details:

 

If you have any question, please contact Sylvie Donnasson: sylvie@editohealth.com

 

PLEASE READ CAREFULLY THE BRIEF BEFORE APPLYING


ABOUT CHIESI:

Chiesi is an international pharma company based in Parma, with 80 years of experience and a strong focus on research, development, production and commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas. With a turn over of more than €1.4 billion sales Chiesi is among the top 50 pharmaceutical companies in the world. Chiesi exports to more than 70 countries with a direct presence in 26. The Chiesi Group employs approximately 4,500 people, 560 dedicated to R&D activities and 700 working at production sites.

X